newsfilter
← Latest News
GlobeNewswire·

CAMP4 Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation ("CAMP4") (NASDAQ:CAMP), a clinical-stage biotechnology company developing a pipeline of regulatory RNA-targeting therapeutics designed